iBio Inc (IBIO)
1.78
+0.06
(+3.49%)
USD |
NYAM |
Apr 22, 16:00
1.79
+0.01
(+0.56%)
After-Hours: 20:00
iBio Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -11.49K% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -688.3% |
| December 31, 2021 | |
| September 30, 2021 | -10.64K% |
| June 30, 2021 | 23.63% |
| March 31, 2021 | -1.00K% |
| December 31, 2020 | -1.15K% |
| September 30, 2020 | -1.84K% |
| June 30, 2020 | -315.9% |
| March 31, 2020 | -4.87K% |
| December 31, 2019 | -1.20K% |
| September 30, 2019 | -4.13K% |
| June 30, 2019 | -566.4% |
| March 31, 2019 | -801.3% |
| December 31, 2018 | -686.5% |
| September 30, 2018 | -9.77K% |
| June 30, 2018 | -4.85K% |
| March 31, 2018 | -5.08K% |
| December 31, 2017 | -2.55K% |
| September 30, 2017 | -3.14K% |
| Date | Value |
|---|---|
| June 30, 2017 | -2.94K% |
| March 31, 2017 | -10.58K% |
| December 31, 2016 | -4.31K% |
| September 30, 2016 | -2.27K% |
| June 30, 2016 | -973.5% |
| March 31, 2016 | -801.1% |
| December 31, 2015 | -1.68K% |
| September 30, 2015 | -1.13K% |
| June 30, 2015 | -596.5% |
| March 31, 2015 | -480.5% |
| December 31, 2014 | -450.4% |
| September 30, 2014 | -172.2% |
| June 30, 2014 | -557.1% |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | -213.5% |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | -525.9% |
| June 30, 2012 | -388.2% |
| March 31, 2012 | -833.5% |
| December 31, 2011 | -683.3% |
| September 30, 2011 | |
| June 30, 2011 | -460.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-11.49K%
Minimum
Sep 2023
23.63%
Maximum
Jun 2021
-3.16K%
Average
-1.18K%
Median
Profit Margin (Quarterly) Benchmarks
| Lixte Biotechnology Holdings Inc | -- |
| PAVmed Inc | -1.34K% |
| Avalo Therapeutics Inc | -1.43K% |
| Imunon Inc | -- |
| Ocugen Inc | -157.3% |